vTv Therapeutics Inc Class A (USD)
VTVT
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range1.89 | 2.08
52-Wk Range |
Last Close2.02
Mkt Cap (m)136.88
Dividend yield-
ISINUS9183851057
Volume146,202
Exchange VenueNAS

Company Profile

vTv Therapeutics Inc is a biopharmaceutical company engaged in drug discovery and development. Its therapies are intended to treat diseases such as Alzheimer's and type-II diabetes. Its other products include TTP399, type II diabetes drug candidate.

Key Information
Price/Earning-
Price/Book0.00
Price/Sales22.14
P/CF-
Rev Growth (3 year avg)63.36
EPS Growth (3 year avg)-
Operating Margin % -755.86
Net Margin %-471.92
Return on Equity-
Debt/Equity-

Documents

Prospectus
en 20/03/2019
Annual Report
en 31/12/2019

Financials

Income Statement
USD201420152016201720182019
Revenue (m)211123
Operating Income (m)-29-38-55-51-20-21
Net Income (m)-36-27-16-16-8-13
Basic EPS-0.90-3.32-1.71-1.67-0.69-0.59
Avg. Diluted Shares Outstanding (m)8810101230
Balance Sheet
USD201420152016201720182019
Current Assets (m)289522033
Non Current Assets (m)1122856
Total Assets (m)1392542899
Current Liabilities (m)7811271913
Total Liabilities (m)------
Total Equity (m)-499-78-91-151-83-49
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-31-37-48-45-27-23
Capital Expenditure (m)
Figures are quoted in USD unless stated otherwise
-
No change
$
2.02
Last Price